PUBLICATIONS

  1. A.L. JENNER, ..., A. GOLDMAN, M. CRAIG (2022), "Agent-based computational modeling of glioblastoma predicts that stromal density is central to oncolytic virus efficacy" iScience

  2. A.P. BROWNING, ..., M.J. SIMPSON, A.L. JENNER (2022), "Identifying cell-to-cell variability in internalisation using flow cytometry" Journal of the Royal Society Interface

  3. C.E. ENGELAND, J.P.W. HEIDBUECHEL, R.P. ARAUJO, A.L. JENNER (2022), "Improving immunovirotherapies: the intersection of mathematical modelling and experiments" ImmunoInformatics

  4. C. DROVANDI, B. LAWSO, A.L. JENNER, A.P. BROWNING (2022), "Population calibration using likelihood-free Bayesian inference" arXiv

  5. A. SURENDRAN,... , A.L. JENNER, M. CRAIG (2022), "Approaches to generating virtual patient cohorts with applications in oncology" bioRxiv

  6. A.L. JENNER, ..., S.J. WADE, K.L. VINE (2022), "Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model" bioRxiv

  7. O. CARDINAL, ... M. CRAIG, A.L. JENNER (2022), "Establishing combination PAC-1 and TRAIL regimens for treating ovarian cancer based on specific pharmacokinetic profiles using in silico clinical trails" Computational and Systems Oncology. 

  8. A.L. JENNERL, R. AOGO, S. ALFONSO, V. CROWE, A.P. SMITH, P.A. MOREL, C.L. DAVIS, A.M. SMITH, M. CRAIG (2020), "COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes" PLOS Pathogens

  9. P. CROSLEY, A. FARKKILA, A.L. JENNER, ..... M. CRAIG, ... M.M. HITT (2020), "Procaspase-activating compound-1 synergizes with TRAIL to induce apoptosis in established granulosa cell tumour cell line (KGN) and primary granulosa cell tumour cells in vitro" International Journal of Molecular Sciences 

  10. Y. WANG, G. AN, A. BECKER, M. CRAIG,.... A.L. JENNER.....P. MACKLIN (2020), "Rapid community-driven development of a SARS-CoV-2 tissue simulator" BioRxiv

  11. A.L. JENNER, T. CASSIDY, K. BELAID, M.C. BOURGEOIS-DAIGNEAULT, M. CRAIG (2020), “In silico trails predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumour aggressivity”, Journal for ImmunoTherapy of Cancer 

  12. S. ALFONSA, A.L. JENNER, M.CRAIG (2020), “Translational approaches to treating dynamical diseases through in silico clinical trails”, Chaos: An interdisciplinary Journal of Nonlinear Science 30:123128

  13. M. CRAIG, A.L. JENNER, B. NAMGUNG, L. LEE, A. GOLDMAN (2020), “Engineering in Medicine to address the challenge of cancer drug resistance: From micro- and nanotechnologies to computational and mathematical modelling”, Chemical Reviews

  14. A.L. JENNER, R.A. AOGO, C.L. DAVIS, A.M. SMITH, M. CRAIG (2020), “Leveraging Computational Modelling to Understand Infectious Diseases”, Current Pathobiology 1-13

  15. A.L. JENNER, F. FRASCOLI, C.O. YUN, P.S. KIM (2020), “Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells”, Applied Science 10(8):2872

  16. T. LEE, A.L. JENNER, P.S. KIM, J.LEE (2020), “Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy”, Mathematical Biosciences and Engineering 17(3): 2361

  17. A.L. JENNER, F. FRASCOLI, A.C.F. COSTER, P.S. KIM (2019), “Enhancing oncolytic virotherapy: Observations from a Voronoi Cell-Based model”, Journal of Theoretical Biology 485: 110052

  18. A.L. JENNER, P.S. KIM, F. FRASCOLI (2019), “Oncolytic virotherapy for tumours following a Gompertz growth law”, Journal of Theoretical Biology 480: 129-140

  19. A.L. JENNER, C.O. YUN, A. YOON, P.S. KIM, A.C.F. COSTER (2018), “Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics”, Journal of Theoretical Biology 454: 41-52

  20. A.L. JENNER, C.O. YUN, A. YOON, A.C.F. COSTER, P.S. KIM (2018), "Modelling combined virotherapy and immunotherapy: strengthening the antitumour immune response mediated by IL-12 and GM-CSF expression", Letters in Biomathematics 5(2): S99-S116

  21. A.L. JENNER, A.C.F. COSTER, P.S. KIM, F. FRASCOLI (2018), “Treating cancerous cells with viruses: insights from a minimal model for oncolytic virotherapy”, Letters in Biomathematics 5(sup1): S117-S136

  22. A.L. JENNER, C.O. YUN, P.S. KIM, A.C.F. COSTER (2018), “Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols”, Bulletin of Mathematical Biology 80(6): 1615-1629

For more details see my google scholar page